Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mineral-ionic Magnesium/Calcium Oral Rinse (THERAVEX® Total Oral Care Plus) in Primary Burning Mouth Syndrome: a Double-blind Randomized Placebo-controlled Trial

NCT07564843 is registered in ClinicalTrials.gov with Biointelligent Technology Systems SL as lead sponsor.

NCT NCT07564843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07564843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mineral-ionic Magnesium/Calcium Oral Rinse (THERAVEX® Total Oral Care Plus) in Primary Burning Mouth Syndrome: a Double-blind Randomized Placebo-controlled Trial
Lead sponsor
Biointelligent Technology Systems SL
Phase
Not applicable
Overall status
Completed
Start date
October 6, 2024
Completion date
September 1, 2025
Enrollment
116 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary burning mouth syndrome (bms)